Related Experiment Videos
Sentinel lymph node biopsy for head and neck melanomas.
Celia Chao1, Sandra L Wong, Michael J Edwards
1Division of Surgical Oncology, James Graham Brown Cancer Center, University of Louisville, Louisville, Kentucky 40202, USA.
Annals of Surgical Oncology
|January 7, 2003
Summary
Sentinel lymph node biopsy for head and neck melanomas presents unique challenges. While H&N melanoma SLNs were less frequently positive, they had higher false-negative rates, suggesting improved techniques are needed.
Area of Science:
- Oncology
- Surgical Pathology
- Dermatology
Background:
- Sentinel lymph node (SLN) biopsy for head and neck (H&N) melanomas is technically challenging due to complex lymphatic drainage.
- This study compares SLN biopsy outcomes for H&N melanomas versus truncal and extremity melanomas.
Purpose of the Study:
- To compare the efficacy and outcomes of sentinel lymph node biopsy in head and neck melanomas against other body locations.
- To identify potential challenges and areas for improvement in SLN biopsy for H&N melanoma.
Main Methods:
- Analysis of data from the Sunbelt Melanoma Trial, including 2610 patients aged 18-70 with melanomas >= 1.0 mm thick.
- Statistical comparison using chi-squared or analysis of variance tests.
- Evaluation of factors including mean SLN per nodal basin, Clark level, Breslow thickness, ulceration, and false-negative rates.
Main Results:
- Head and neck melanomas had a higher false-negative rate (1.5%) compared to trunk/extremity (0.5%) but fewer positive SLNs (15% vs. 23.4%/19.5%).
- Peri-parotid SLN identification occurred in 25% of cases with no reported facial nerve injuries.
- Blue dye visualization was less frequent in H&N melanoma SLNs.
Conclusions:
- Sentinel lymph node biopsy for head and neck melanomas shows distinct results compared to other sites.
- Preoperative lymphoscintigraphy and meticulous intraoperative node detection may enhance SLN biopsy outcomes for H&N melanomas.